| 期 |
栏目 |
标题 |
文件 |
| 卷 8, 编号 9 (2022) |
Articles |
PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: FOCUS ON APIXABAN |
|
| 编号 3 (2018) |
Articles |
Choosing wisely: doing more does not mean doing better |
|
| 编号 3 (2018) |
Articles |
Risk factors for the development of obstructive shock in patients with pulmonary embolism |
|
| 编号 3 (2018) |
Articles |
A heart fatty acid binding protein the diagnosis and prognosis of acute coronary syndrome: new possibilities or lost illusions |
|
| 编号 5 (2018) |
Articles |
Case of primary antiphospholipid syndrome complicated by thrombotic kidney microangiopathy of with infective endocardite addition |
|
| 卷 7, 编号 4 (2021) |
Articles |
Direct oral anticoagulants - a new standard in the treatment of diseases associated with thrombosis |
|
| 卷 7, 编号 5 (2021) |
Articles |
Treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: is there a light at the end of the tunnel? |
|
| 卷 7, 编号 10 (2021) |
Articles |
Acetylsalicylic acid in the treatment of patients with new coronavirus infection (COVID-19): pro and contra |
|
| 卷 8, 编号 1 (2022) |
Articles |
Alirocumab in patients of very high cardiovascular risk |
|
| 卷 8, 编号 1 (2022) |
Articles |
Combined hypolipidemic therapy for mixed atherogenic dyslipidemia: review |
|
| 卷 9, 编号 4 (2023) |
REVIEWS |
Lipid-lowering therapy today and tomorrow |
|
| 卷 9, 编号 4 (2023) |
HELPING PRACTICING PHYSICIAN |
New opportunities for chronic heart failure patients’ treatment: focus at dapagliflosin |
|
| 卷 9, 编号 6 (2023) |
REVIEWS |
Based on materials of community-acquired pneumonia – an European Federation of internal medicine guideline critical appraisal adaptation for internists: important answers to difficult questions |
|
| 卷 9, 编号 9 (2023) |
CLINICAL CASE |
Infectious endocarditis in a patient with a transplanted kidney on a conventional hemodialysis |
|
| 卷 10, 编号 4 (2024) |
REVIEWS |
Unsolved mysteries of “broken heart” syndrome |
|
